ArticleDrug design, development and therapy2025

From Oral to Sublingual: A Redefined Avanafil Tablet with a Breakthrough in Bioavailability and First-Pass Metabolism Avoidance.

Turky Omar Asar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.